Vivos Inc. stock discussion
RDGL - Advanced Cancer Therapy for Pets – IsoPet® by Vivos Inc.Road Trip and Outreach: Spreading Awareness and Educating Vets on IsoPet®
tradersque.com/advanced-cancer-therapy-for-pets-isopet-by-vivos-inc/
RDGL $.50 incoming prior to IDE submission within next 50 days. submission to occur prior to end of Q2, Friday June 28, 2024 imoRDGL - Possible to see a healthy consolidation inside the upper flag (blue). New longs will hold, and organic trading of gains can be expected.Moving Trend 0.1087
Hourly Resistance 0.11
Daily Resistance is 0.1148
Hourly Support 0.095
Daily Support 0.0876
Daily volume above 774K is ideal for a continuation pattern to prevail towards the end of week 16.
Statistically Price Action above 0.15 could lead to a thin 30% float volatility. IMO GLTA
twitter.com/QueTraders/status/1779704015216930940
RDGL– Vivos Inc. (OTCQB)Weekly Highlight: 3 consecutive weeks as a top performer with a move of 11.73% for week 14 and additional 33.33% increase in week 15.
Closing Price: $.1044 with recent weekly high of $.1148 and 48.5% total ROI since our coverage began March 27th. tradersque.com/vivos-inc-innovation-in-precision-radionuclide-therapy/
Volume Buzz: 3.31M shares traded above 10-day average volume of 774K.
Why Watch: Anticipation of potential new IsoPet clinics and Company confirmed IDE submission final details, Q1 report is being finalized and New Vivos website